New drug DD-S052P takes first step in human testing
Knowledge-focused
Completed
This early-stage study tested the safety of a new drug called DD-S052P in 64 healthy adults. Participants received either the drug or a placebo through an IV, with some getting a single dose and others multiple doses over several days. The goal was to check for side effects and h…
Phase: PHASE1 • Sponsor: HLB Science • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC